Zeller, Mark
Nuyts, Valerie
Heylen, Elisabeth
De Coster, Sarah
Conceição-Neto, Nádia
Van Ranst, Marc
Matthijnssens, Jelle
Article History
Received: 22 September 2015
Accepted: 19 October 2016
First Online: 14 November 2016
Change Date: 3 January 2017
Change Type: Update
Change Details: A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing interests
: J.M. serves as a consultant for GlaxoSmithKline on the genetic stability and safety aspects of the rotavirus G1P[8] vaccine strain (Rotarix). The authors declare no other competing financial interests.